FFPE tissue sections immunostained to detect the tumor cell proliferation marker Ki67 showed that compared to vehicle controls and gemcitabine alone, JQ1 + gemcitabine decreased the Ki67 index ~3- to 8-fold in both models (P < 0.05) (Figure 3E–H). Here, MKI67 is linked to neoplasm.